Synergistic effects and related bioactive mechanism of Potentilla fruticosa L. leaves combined with Ginkgo biloba extracts studied with microbial test system (MTS) by Ze-Hua Liu et al.
RESEARCH ARTICLE Open Access
Synergistic effects and related bioactive
mechanism of Potentilla fruticosa L. leaves
combined with Ginkgo biloba extracts
studied with microbial test system (MTS)
Ze-Hua Liu, Dong-Mei Wang*, Su-Fang Fan, Deng-Wu Li* and Zi-Wen Luo
Abstract
Background: Potentilla fruticosa, also called “Jinlaomei” and “Gesanghua”, is widely used as folk herbs in traditional
Tibetan medicine in China to treat inflammations, wounds, certain forms of cancer, diarrhoea, diabetes and other
ailments. Previous research found P. fruticosa leaf extract (C-3) combined with Ginkgo biloba extracts (EGb) showed
obvious synergistic effects in a variety of oxidation systems. The aim of the present study was to further confirm the
synergy of P. fruticosa combined with EGb viewed from physiological bioavailability and explore the related bioactive
mechanism behind the synergism.
Methods: The microbial test system (MTS) was adopted to evaluate the related bioactive mechanism. The synergistic
effects were evaluated by isobolographic analysis. The H2O2 production rate and antioxidant enzyme (Catalase (CAT),
Peroxidase (POD), Superoxide dismutase (SOD), Glutathione peroxidase (GSH-PX)) activities were determined by the
colorimetric method. Enzyme gene (CAT, SOD) expression was measured by real time-PCR.
Results: The MTS antioxidant activity results showed the combination of C-3 + EGb exhibited synergistic effects
especially at the ratio 5:1. Components of isorhamnetin and caffeic acid in C-3 and EGb displayed strong
antioxidant activities on MTS and their combination also showed significant synergy in promoting H2O2
production. The combinations of C-3 + EGb and isorhamnetin + caffeic acid promoted CAT and SOD enzyme
activities and the ratio 1:1 exhibited the strongest synergy while no obvious promotion on POD and GSH-PX
enzyme activities was found. Both combinations above promoted gene expression of CAT and SOD enzymes
and the ratio 1:1 exhibited the strongest synergy.
Conclusions: Antioxidant activity results in MTS further confirmed the significant synergy of C-3 combined
with EGb and isorhamnetin combined with caffeic acid. The synergy of C-3 combined with EGb may be
attributed to the combination of isorhamnetin + caffeic acid, which promoted CAT and SOD enzyme gene
expression and further promoted the enzyme activities in E. coli. This study could further provide rational basis
for optimizing the physiological bioavailability of P. fruticosa by using natural and safe antioxidants in low
doses to produce new medicines and functional products.
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Background
Previous research has revealed that many plant antioxi-
dants can protect against oxidation damage and they
may even have potential applications in preventing vari-
ous diseases [1]. Their human use has a good safety rec-
ord when consumed in reasonable amounts, however,
when used in large amounts the safety effects are un-
known [2]. Considering the high values of plant antioxi-
dants and their related products, a detailed quantitative
analysis of the phytochemical profiles and biological
properties, especially of antioxidant combinations with
known synergistic effects seem to be a useful exercise.
P. fruticosa belonging to the rosaceae family, widely
distributed in cool temperate, high altitude regions of
the northern hemisphere [3]. In China, the plant species
P. fruticosa also called “Jinlaomei” and “Gesanghua”, has
long been utilized as folk herbs especially in traditional
Tibetan medicine for its superior therapeutic effects
[4, 6]. The leaf extracts of P. fruticosa were used to
prevent cardiac-cerebral vascular disease, the stem ex-
tracts of P. fruticosa were used to treat inflammation,
dyspepsia and edema in traditional Tibetan medicine
[7–9]. It was also reported that the curative proper-
ties of P. fruticosa were used to treat certain types of
cancer; bacterial, fungal and viral infections; diabetes
and other ailments [10–17]. Furthermore, the extracts
of P. fruticosa possess relatively high concentrations
of phenolic acids and flavonoids and powerful radical
scavenging capacity, which was higher than that of
butylated hydroxytoluene [18–20]. Meanwhile, Gingko
biloba extracts have gained acceptance in industry as
a promising source of antioxidant compounds and the
radical scavenging capacities of P. fruticosa extracts
were even higher than that of the synthetic antioxi-
dant butylated hydroxytoluene (BHT) used as antioxi-
dant in pharmaceutical preparations and cosmetic
formulations [21–23].
In consideration of the rational basis for the use of
phytochemicals in P. fruticosa and EGb were still poorly
explored by chemical methods including DPPH, ABTS,
FRAP, and the oxygen radical absorbance capacity
(ORAC) assay, a strategy to enhance the physiological
bioavailability of P. fruticosa combined with EGb seems
to be imperative [4, 24–26]. According to the results of
previous study, the combination of P. fruticosa and EGb
showed enhanced activity in achieving a superior syner-
gism outcome directed at the free radical oxidant damage.
Among the combinations of the 6 phenolic compounds
(catechin, caffeic acid, hyperoside, rutin, ellagic acid
and quercetin) in P. fruticosa and the 4 phenolic
compounds (catechin, quercetin, kaempferide and iso-
rhamnetin) in EGb detected by chromatographic frac-
tionation, isorhamnetin combined with caffeic acid
displayed the greatest synergistic effects [6]. However,
the observation in antioxidant synergistic effects of P.
fruticosa combined with EGb is still not enough to
guide in-depth pharmaceutical applications of P. fruti-
cosa. This experiment carried on the modified and
improved assay based on microbial test system (MTS)
in our lab [27], focused on the physiological bioavail-
ability to further confirm the synergistic effects of P.
fruticosa combined with EGb and try to find specific
combinations with least concentrations that exhibit
synergistic effects. Those compounds may help to
produce natural and safe antioxidants products in
lower doses instead of synthetic antioxidants.
In this consideration, the objectives for this study
were: (1) to further confirm the antioxidant synergistic
effects of P. fruticosa (C-3) combined with EGb studied
with MTS assay viewed from physiological bioavailabil-
ity; (2) to evaluate the antioxidant enzyme activities and
gene expression to further explore the related bioactive
mechanism of P. fruticosa (C-3) combined with EGb; (3)
to provide rational basis to optimize the antioxidant
capacity and physiological bioavailability of P. fruticosa
using natural and safe antioxidants in low doses instead
of synthetic antioxidants, which might be useful to pro-
duce new medicines and functional products.
Methods
Plant materials and preparation on the C-3 extracts of P.
fruticosa
P. fruticosa leaves were collected from Huzhu Northern
Mountain, Qinghai during 2014 at an altitude of 2940 m
(E 102°21.149′, N 36°55.807′) [5]. The voucher specimen
was identified by the professor Dengwu Li and was de-
posited at Herbarium of the Northwest A&F University,
Yangling, China (WUK0780381). The crude extracts of
P. fruticosa were the acetone extraction phase (C-3)
extracted by Wang in our lab [6]. The air-dried, ground
leaves of P. fruticosa were extracted with 80% acetone
for three days at room temperature to obtain the crude
acetone extracts. Part of them were further partitioned
with ethyl acetate extracts and then subjected to column
chromatography (15 cm diameter, 120 cm length) with
silica gel as stationary phase. The elution of components
present in the extract was then dissolved in different
concentration gradient of ether/acetone (4:1, 1:1, 1:5 and
0:1 v/v). The third fraction labeled as C-3 was found to
be most active in the assay, so the C-3 fraction was
selected for further research. Both of the C-3 and EGb
extracts were dissolved in the initial concentration of
5 mg/ml and the individual compounds were dissolved
in the concentration of 1 mM.
Bacteria and chemicals
E.coli (ATCC No.25922) (Microbial Culture Collection
Center of Guangdong Institute of Microbiology, China);
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Ginkgo biloba extracts, EGb 761, standard at European
Pharmacopeia (Shanghai Youxin Biological Science and
Technology Co., Ltd. PR China); quercetin, catechin, caf-
feic acid, rutin, hyperoside, kaempferide, ellagic acid and
isorhamnetin (Shanghai Yuanye Industrial Co., Ltd. PR
China); sodium dihydrogen phosphate, disodium hydro-
gen phosphate, sodium chloride, potassium chloride, po-
tassium dihydrogen phosphate, hydrogen peroxide 30%
(Guangdong Guanghua Chemical Factory Co., Ltd. PR
China), dimethyl sulfoxide (DMSO) (Tianjin Bodi Chem-
ical Factroy Co., Ltd. PR China), horseradish peroxidase;
Yeast extract, Tryptone (OXOID Ltd., Basingstoke,
Hampshire, England). All reagents and solvents used
were of analytical grade. Deionized water (0.055 μS/cm)
was used to prepare aqueous solutions.
Determination of antioxidant synergy effects on MTS
To circumvent the limitations of the assays based on
chemical mechanism to determine antioxidant synergis-
tic effects, the MTS assay was adopted to measure the
bioavailability behind synergism with some modification
[27]. Bacteria were cultivated aerobically overnight in LB
medium in shaking bed (37 °C, 120 rpm). Cell growth
was monitored by measurement of the optical density at
600 nm. One milliliter of cell suspension added to
9.0 ml of LB medium to final OD600 = 0.250 ± 0.004.
Subsequently, 100 μL of sample (5 mg/ml), 1 ml of the
diluted cell suspension and 8.9 ml LB medium were
mixed and incubated at 37 °C (180 rpm, 1.5 h).121 After
the addition of 6.0 mM H2O2 we calculated the μ value
at 30 min to assess the antioxidant activity of extracts.
The specific growth rate for each sample was calculated
according to the following equation:




Where μ was the specific growth rate, N0 and N were
the optical density at time zero and t. The protective ac-
tivity of each sample was calculated as follows: the spe-
cific growth rate of the E. coli-containing samples and
6.0 mM H2O2 was divided by the specific growth rate of
the samples containing only H2O2. All measurements
were done in triplicate.
Measurement of H2O2 production rate
Rate of hydrogen peroxide production in phosphate
medium was assayed by Amplex Red-horseradish perox-
idase detecting system (AR/HRP) [28]. The solutions of
studied compounds was prepared freshly. One milligram
of AR was dissolved in 0.78 ml of DMSO, and 0.75 ml of
this solution was then diluted into 18 ml of 50 mM po-
tassium phosphate (KPi, pH 7.8) to generate a 200 μM
stock solution, which was shielded from light. HRP was
dissolved in 50 mM KPi (pH 7.8) to 0.02 mg/ml. In
order to measure H2O2, 1 ml sample was mixed with
20 μL HRP and 200 μL AR. H2O2 concentration in sam-
ples was measured using a Shimadzu RF Mini-150
fluorometer (λex563 nm and λem587 nm) at 0 and
15 min after incubation had started. Note that a small
amount of H2O2 is generated by the dye/HRP detection
system itself, this amount was accounted for by the
standard curve.
Preparation of crude enzyme liquid
Bacteria suspension was put into ultrasonic cell crusher
and set the parameter as: 5 s chill time, 2 s cell broke
time, 11 min total work time, 15 °C liquid temperature.
The instrument power must be guaranteed at 350 Hz.
Centrifuge the cell disruption liquid for 8000 rpm in
8 min and filter to get the solution.
Determination of enzyme activities
Catalase (CAT) enzyme
CAT enzyme activity was assayed according to the
method of Beers with some modification [29]. Reaction
system consists of the following substances: 3 ml PBS
buffer, 0.1 ml 300 mM/L H2O2, 0.5 ml crude enzyme
liquid. Add the PBS buffer into the control groups. Imme-
diately detect absorbance values under 240 nm in every
30 s for 2 minutes. Take the 0.1 decrease of OD240 in one
minute for one unit of enzyme activity. CAT enzyme ac-
tivity was calculated according to the following equation:
Y U⋅g1⋅min1
  ¼ ΔA240  Vt
0:1 Vs  t Fm
Above the formula,
ΔA240 ¼ A0  AS1 þ AS22
A0 was the initial absorbance, AS1, AS2 were the sample
absorbance, Vt was the enzyme liquid volume, Fm was
sample mass, t was the total time of detection (2 min).
Peroxidase (POD) enzyme
The method to determinate the activity of POD enzyme
was performed according to Huang with some modifica-
tion [30]. All measurements were done in triplicate. Sub-
stances followed: 2 ml 0.3% H2O2, 1 ml 0.2% guaiacol,
0.5 ml crude enzyme liquid and 1 ml PBS buffer were
added into the reaction system. The PBS buffer was
added into the control groups instead. Put the reaction
system into water bath for 10 min then add the meta-
phosphate termination reaction. The reaction value was
monitored under the 470 nm absorbance before and
after water bath. POD enzyme activity was calculated ac-
cording to the following equation:
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Y U⋅g1⋅min1
  ¼ ΔA470  Vt
0:01m Vs  t
Above the formula, ΔA470 was the change of the ab-
sorbance during reaction, m was the sample mass, Vt
was the total volume of enzyme liquid, Vs was the con-
suming enzyme liquid volume of reaction, t was the re-
sponse time.
Superoxide dismutase (SOD) enzyme
The method to determinate the activity of SOD enzyme
was performed according to Weng with some modifica-
tion [31]. Included in the reaction system, there were
0.5 ml Met (130 mmol/L), 0.5 ml NBT (750 μmol/L),
0.5 ml EDTA•Na2 (100 μmol/L), 0.5 ml riboflavin
(20 μmol/L), 1 ml PBS buffer and 0.5 ml crude enzyme
liquid. The tubes were exposed evenly under 4000 xl
fluorescent for 20 min, and then monitored under
560 nm absorbance. The 50% nitroblue tetrazolium re-
duction inhibition under light was taken as one unit of
enzyme activity. SOD enzyme activity was calculated ac-
cording to the following equation:
Y U⋅g1⋅min1
  ¼ At  Asð Þ  Vs  V
0:5 Ack  Vt  t Fm
Above the formula, At was the absorbance of the con-
trol group, As was the sample absorbance, Vt was the
volume of samples, Vs was the total volume of enzyme
liquid, t was the response time.
Glutathione peroxidase (GSH-PX)
GSH-PX enzyme activity of the tested compounds was
assayed by the method described by Xing with some
modification [32]. Reaction system consists of the fol-
lowing substances: 0.5 ml GSH-PX standard substances,
1.5 ml double distilled water, 2 ml PBS buffer and 0.1 ml
TDNB. All measurements were done in three parallel
and the PBS buffer was added into control groups. The
samples were reacted for 5 min at room temperature,
then the optical absorbance was monitored under
412 nm. GSH-PX enzyme activity was calculated accord-
ing to the following equation:
Y μ⋅g1FW
  ¼ C Vt
Vs  Fm
Above the formula, C was the GSH-PX enzyme con-
centration in samples calculated from the standard
curves, Vt was the total volume of enzyme liquid, Vs was
the volume of samples, Fm was the sample mass.
CAT and SOD gene expression by real-time PCR
Gene sequences of CAT and SOD enzyme from E. coli
were obtained from the GenBank database and gyrB was
used as a reference gene. The primers were designed by
Primer premier 5 and Oligo 6.0. The primer sequence of
CAT enzyme is: forward primer: 5′-TGGAGTGAATAC
CACGACGAT-3′, reverse primer: 5′-CATGGAAGC
CATCACAAACG-3′, product size is 286 bp; The primer
sequence of SODa is: forward primer: 5′-CCCTGC
CATCCCTGCCGTAT-3′, reverse primer: 5′-GTGACC
GCCAGCGTTGTTGC-3′, product size is 227 bp; The
primer sequence of SODb is: forward primer: 5′-TCAC
TACGGCAAGCACCA-3′, reverse primer: 5′- CAGG
CAGTTCCAGTAGAAAGTA-3′, product size is 166 bp;
The primer sequence of SODc is: forward primer: 5′-
CCAGCGGTTTAGGTTGAT-3′, reverse primer: 5′-
TGA AGGGCCAGAAGGTG-3′, product size is 179 bp;
The primer sequence of gyrB is: forward primer: 5′-
CGGAATGTTGTTGGTAAAGC-3′, reverse primer: 5′-
CGTGACGGCAAAGAAGAC-3′, product size is 198 bp.
Total RNA samples from E. coli strains were extracted
by total RNA isolation kit and treated with DNaseI
(Beijing Kang Wei, Biotechnology Industrial Co., Ltd. PR
China) to remove genomic DNA contamination. Reverse
transcription was performed in a total volume of 20 μL
with HiFiScript cDNA first chain synthesis kit (Beijing
Kang Wei, Biotechnology Industrial Co., Ltd. PR China).
The reaction system contains 4 μL dNTP Mix (2.5 mM
each), 2 μL Primer Mix, 2 μL RNA Template, 4 μL 5 ×
RT Buffer, 2 μL DTT (0.1 M), 1 μL HiFiScript (200 U/μL)
and 5 μL RNase-Free Water. The condition was followed
by 42 °C for 40 min, 85 °C for 5 min, as recommended by
the manufacturer.
Real-time PCR reactions were performed with Ultra
SYBR Mixture, using IQ5 fluorescence quantitative ana-
lysis software. The thermal cycling conditions comprised
an initial step at 94 °C for 4 min, followed by 40 cycles
at 94 °C for 30 s, 55 °C for 30 s, and 72 °C for 30 s and
then 61 cycles of temperature programming at 65 °C.
The change in fluorescence of Ultra SYBR Mixture in
every cycle was monitored by the system software, and
the threshold cycle (CT) was measured. Gene expression
level of the cells exposed to FLC relative to that of the
control cells was calculated using the formula 2-ΔΔCT,
where ΔCT was the CT value of genes of interest minus
that of the internal control, and ΔΔCT was the mean
ΔCT value of the cells exposed to FLC and/or BBR
minus that of the control cells. Reactions were per-
formed in triplicate with independent RNA isolations.
Isobolographic analysis
The isobolographic analysis was performed according to
the method described by Wang in our lab with some
modification [6]. To show the interactions (synergistic,
additive or antagonistic), all extracts were prepared at
5 mg/ml and individual compounds at 10 mmol/L in
various combinations (ratios of 5:1, 3:1, 1:1, 1:3 and 1:5,
v/v). If the observed dose of combination was on the
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additivity isobole or close to it, this indicates no inter-
action; measurements below and above the additivity
isobole indicates antagonism and synergism, respectively
[33–37]. In addition, the interaction index, denoted γ,
was introduced to further measure the effects of differ-
ent combinations:
a=Að Þ þ b=Bð Þ ¼ γ
Where A and B are the doses of drug A (alone) and B
(alone), respectively, that give the specified effect and (a,
b) is the combination dose that produces this effect
level. If γ = 1, the interaction is additive, if γ < 1, it is an-
tagonistic, and if γ > 1, it is synergistic.
Statistical analysis
Expected values (E) were calculated as the average of in-
dividual observed amounts for each one of two com-
bined extracts or compounds, and observed values(O)
came through the observed amounts for combined ex-
tracts or compounds [38, 39]. All results were expressed
as the mean ± standard deviation (SD). The significant
difference was calculated by SPSS 20.0 one-way ANOVA
followed by Duncan’s test; values < 0.05 were considered
to be significant. All diagrams were draw by Sigmaplot
12.0 and Photoshop 8.0.
Results and discussion
MTS antioxidant activity of C-3, EGb and their
combinations
Previous research of Wang [6] found that phase C-3 was
the most effective fraction isolated from P. fruticosa
extracts which could be selected as the main section to
explore the synergy mechanism. Therefore, C-3 was
combined with EGb to produce natural powerful com-
bined antioxidants of P. fruticosa. The protective effects
of C-3, EGb and their combinations on MTS was first
assessed and quercetin was used as the positive control.
The results showed that C-3, EGb and their combina-
tions could better increase cell growth rate than quercetin
under oxidative stress. All combinations of C-3 + EGb ex-
hibited synergistic effect and the ratio 5:1 showed stron-
gest synergy with μ30 value of 1.603 ± 0.017, followed by
3:1 (1.411 ± 0.016), 1:3 (1.400 ± 0.012), 1:5 (1.376 ± 0.010),
and 1:1 (1.366 ± 0.018) (Fig. 1).
In summary, C-3 combined with EGb displayed synergis-
tic effects on MTS and the ratio 5:1 (C-3: EGb) displayed
the strongest synergistic, which was in accordance with the
results showed in Wang’s research. The results showed
that the combination of C-3 + EGb displayed significant
antioxidant activity in E.coli viewed from bioavailability as
well as in antioxidant assays based on chemical methods.
This further suggested that EGb could be selected to
promote the antioxidant capacity of P. fruticosa in order to
produce natural powerful combined antioxidants.
MTS antioxidant activity of individual compounds in C-3
and EGb
To identify above-mentioned phenomena, further study
in MTS antioxidant activity of individual compounds in
C-3 (catechin, caffeic acid, hyperoside, rutin, ellagic acid
and quercetin) and EGb (catechin, quercetin, kaempfer-
ide and isorhamnetin) were carried out to explore the
mechanism behind the synergism. It is previously re-
ported that these compounds showed relatively high
antioxidant capacities respectively [40].
The protective effect of individual compounds, as de-
termined on MTS, was presented in Fig. 2. Among the
main phenolics in C-3 and EGb, caffeic acid and iso-
rhamnetin showed a notable protective effect with μ30
values of 1.407 ± 0.021 and 1.317 ± 0.017, which were
higher than those of the other metabolites.
Since the individual compounds of caffeic acid and
isorhamnetin displayed significant synergistic effects on
MTS, the protective effects in MTS was likely a result of
Fig. 1 Synergistic effect of C-3, EGb and C-3 combined with EGb on
MTS antioxidant activity
Fig. 2 Antioxidant activity of catechin, quercetin, kaempferide,
isorhamnetin, caffeic acid, rutin, ellagic acid and hyperoside on MTS
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the existing phytochemicals therein C-3 and EGb.
Therefore, isorhamnetin and caffeic acid may played a
great role in the synergy observed in the combination of
C-3 + EGb, and the results further suggests that the re-
lated bioactive mechanism of Potentilla fruticosa L.
leaves combined with Ginkgo biloba extracts may linked
to the reaction of individual compounds therein the C-3
and EGb.
Synergistic effects of C-3 with 4 compounds in EGb on
MTS antioxidant activity
The results above-mentioned suggested that the syner-
gistic protective effect was likely due to the high activity
as revealed in isorhamnetin and caffeic acid. What’s
more, currant literature observed that synergistic actions
displayed when crude extracts combined with natural
antioxidants [36, 38]. Thus the C-3 was added to the
other 4 compounds in EGb on MTS and the protective
effects of the combinations was analyzed.
Isobolographic plot of the combinations of C-3 with 4
compounds in EGb was showed in Fig. 3. The observed
antioxidant capacity of each mixture was compared with
the expected value (Table 1) which was based on the iso-
bologram. In general, no antagonistic effect was found in
testing of the combinations and the combination of
C-3 + isorhamnetin displayed obvious synergism followed
by 1:1 (γ = 1.622) > 5:1 (γ = 1.561) > 3:1 (γ = 1.372) > 1:3
(γ = 1.265) > 1:5 (γ = 1.128).
Accordingly, these results indicated that there was no
obvious synergistic effect among C-3 and other 3 com-
pounds, thus isorhamnetin may played an important role
in the synergy of C-3 and EGb combination. Therefore,
isorhamnetin were chosen as the specific compounds for
further explore the synergistic effects of 6 compounds in
C-3 with EGb to find specific combinations with least
concentrations that exhibit synergistic effects of C-3
combined with EGb.
Synergistic effects of 6 compounds in C-3 with isorhamnetin
on MTS antioxidant activity
Similarly, to assess how interactions of C-3 and isorhamne-
tin contribute to the synergistic protective effects, isorham-
netin was added to the other 6 compounds in C-3 on MTS
and the protective effect of the combinations was detected.
The results in Table 2 and Fig. 4 illustrated that major-
ity compounds in C-3 combined with isorhamnetin just
showed simple additive effect, there was no significant
difference between observed values and expected values
(p < 0.05). However, the combination of isorhamnetin +
caffeic acid showed obvious synergism and the ratio
1:1 exhibited the strongest antioxidant activity on MTS
(γ = 1.488) followed by 3:1 (γ = 1.295) > 5:1 (γ = 1.192) >
1:3 (γ = 1.009) > 1:5 (γ = 1.004).
In conclusion, the observation suggested that the syner-
gistic protective effect response in C-3 + EGb may be due
to the interacting of isorhamnetin and caffeic acid. Fur-
thermore, the combinations of C-3 + EGb and isorhamne-
tin + caffeic acid were selected to reveal the related
bioactive mechanism behind this synergism. Moerover,
the ratio of 1:1 (isorhamnetin: caffeic acid) may be chosen
as the best ratio that exhibited the synergistic effects in
the combination of C-3 and EGb.
Fig. 3 Isobolographic plot of C-3 + catechin, C-3 + quercetin, C-3 + kaempferide and C-3 + isorhamnetin on MTS antioxidant activity
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Influence of C-3 + EGb and isorhamnetin + caffeic acid on
H2O2 antioxidant production rate
Previous research showed that the antioxidant capacity
of the combinations and their autoxidation of H2O2 pro-
ducing ability are proportional to the relationship [28].
The results in Table 3 showed that the combination of
C-3 + EGb generally displayed an additive effect while
5:1 displayed synergism (γ = 1.192). Furthermore, iso-
rhamnetin + caffeic acid showed a trend of synergism
in which 1:1 displayed the strongest synergism (γ = 1.536).
This suggested that the presence of isorhamnetin
and caffeic acid played a great role in the synergy
observed.
Among the results detected, the combination of C-3 +
EGb and isorhamnetin + caffeic acid showed synergistic
on H2O2 antioxidant production rate, which was in ac-
cordance with the results above on MTS. It was sug-
gested that the synergism response in C-3 + EGb may be
due to the interacting of isorhamnetin and caffeic acid,
thus the combination of C-3 + EGb and isorhamnetin +
caffeic acid were picked out to in-depth explore the
related bioactive mechanism behind synergy through
the determination of enzymatic antioxidant activites
in E. coli.
Influence of C-3 + EGb and isorhamnetin + caffeic acid on
CAT, POD, SOD and GSH enzyme activities
To ascertain the root cause why the combinations above
promoted the protective effect on MTS, the activities of
four main antioxidant enzymes (CAT, POD, SOD and
Table 2 Synergistic effects of isorhamnetin + catechin,
isorhamnetin + caffeic acid, isorhamnetin + rutin, isorhamnetin +
ellagic acid, isorhamnetin + hyperoside and isorhamnetin +
quercetin on MTS antioxidant activity
Combinations Ratios Test on growth inhibition
O E γ
Isorhamnetin + Catechin 5:1 0.967 ± 0.012* 1.189 ± 0.014 0.813
3:1 0.952 ± 0.016* 1.165 ± 0.018 0.817
1:1 0.921 ± 0.013* 1.094 ± 0.012 0.841
1:3 0.938 ± 0.008* 1.023 ± 0.010 0.917
1:5 0.957 ± 0.016* 0.999 ± 0.009 0.958
Isorhamnetin + Caffeic acid 5:1 1.834 ± 0.002* 1.538 ± 0.003 1.192
3:1 1.984 ± 0.018* 1.532 ± 0.018 1.295
1:1 2.254 ± 0.037* 1.515 ± 0.035 1.488
1:3 1.511 ± 0.016* 1.497 ± 0.011 1.009
1:5 1.497 ± 0.015* 1.491 ± 0.020 1.004
Isorhamnetin + Rutin 5:1 1.239 ± 0.009 1.248 ± 0.010 0.993
3:1 1.218 ± 0.013 1.217 ± 0.016 1.001
1:1 1.103 ± 0.012 1.122 ± 0.013 0.983
1:3 1.011 ± 0.011 1.027 ± 0.011 0.984
1:5 1.039 ± 0.012* 0.996 ± 0.013 1.043
Isorhamnetin + Ellagic acid 5:1 1.379 ± 0.015 1.389 ± 0.010 0.993
3:1 1.386 ± 0.009 1.330 ± 0.007 1.042
1:1 1.192 ± 0.009 1.152 ± 0.008 1.035
1:3 1.007 ± 0.009 0.973 ± 0.013 1.035
1:5 0.963 ± 0.015 0.914 ± 0.010 1.053
Isorhamnetin + Hyperoside 5:1 1.360 ± 0.015 1.367 ± 0.016 0.995
3:1 0.996 ± 0.011 0.987 ± 0.009 1.009
1:1 0.992 ± 0.007 0.994 ± 0.009 0.999
1:3 1.004 ± 0.008 1.000 ± 0.010 1.004
1:5 0.993 ± 0.010 1.002 ± 0.010 0.991
Isorhamnetin + Quercetin 5:1 1.384 ± 0.014 1.367 ± 0.014 1.012
3:1 1.674 ± 0.008 1.673 ± 0.007 1.001
1:1 1.501 ± 0.009* 1.490 ± 0.015 1.008
1:3 1.310 ± 0.015 1.307 ± 0.010 1.002
1:5 1.247 ± 0.086 1.246 ± 0.001 1.001
Values are the mean of three replicates ± SD (n = 3)
The asterisk indicates a significant difference between observed value and
expected value (p < 0.05). O, observed value; E, expected value; γ,
interaction index
Table 1 Synergistic effects of C-3 + catechin, C-3 + quercetin,
C-3 + kaempferide and C-3 + isorhamnetin on MTS antioxidant
activity
Combinations Ratios Test on growth inhibition
O E γ
C-3 + Catechin 5:1 0.746 ± 0.019 0.783 ± 0.008 0.954
3:1 1.043 ± 0.010 0.954 ± 0.009 1.094
1:1 1.701 ± 0.015* 1.467 ± 0.019 1.159
1:3 2.118 ± 0.013 1.981 ± 0.012 1.069
1:5 2.131 ± 0.016 2.152 ± 0.013 0.990
C-3 + Quercetin 5:1 1.320 ± 0.017 1.367 ± 0.017 0.966
3:1 1.459 ± 0.083 1.323 ± 0.013 1.102
1:1 1.321 ± 0.010 1.127 ± 0.013 1.172
1:3 0.942 ± 0.012* 0.931 ± 0.017 1.012
1:5 0.854 ± 0.017 0.865 ± 0.010 0.987
C-3 + Kaempferide 5:1 1.350 ± 0.006* 1.367 ± 0.008 0.987
3:1 1.379 ± 0.087 1.375 ± 0.055 1.003
1:1 1.030 ± 0.018 1.048 ± 0.020 0.983
1:3 0.716 ± 0.013 0.721 ± 0.015 0.994
1:5 0.608 ± 0.013 0.612 ± 0.013 0.995
C-3 + Isorhamnetin 5:1 2.134 ± 0.018* 1.367 ± 0.009 1.561
3:1 1.704 ± 0.020* 1.242 ± 0.021 1.372
1:1 2.093 ± 0.017* 1.290 ± 0.012 1.622
1:3 1.693 ± 0.015* 1.338 ± 0.014 1.265
1:5 1.528 ± 0.013* 1.354 ± 0.016 1.128
Values are the mean of three replicates ± SD (n = 3)
The asterisk indicates a significant difference between observed value and
expected value (p < 0.05). O, observed value; E, expected value; γ,
interaction index
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GSH-PX) in E. coli were determined. Results showed
that both the combinations of C-3 + EGb and iso-
rhamnetin + caffeic acid promoted CAT and SOD en-
zyme activities and the proportion of 1:1 exhibited
the strongest effect with value of 13.175 ± 0.071 U/mg
prot, 105.125 ± 0.073 U/mg prot, 10.699 ± 0.101 U/mg
prot and 125.970 ± 1.681 U/mg prot (Table 4). How-
ever, these two combinations did not affect much on
POD and GSH enzyme activities. All these experimental
results above highlighted that synergy response in the
combination of C-3 + EGb had a correlation with iso-
rhamnetin + caffeic acid.
Fig. 4 Isobolographic plot of isorhamnetin + catechin, isorhamnetin + caffeic acid, isorhamnetin + rutin, isorhamnetin + ellagic acid, isorhamnetin +
hyperoside, isorhamnetin + quercetin on MTS antioxidant activity
Table 3 H2O2 production rate of C-3 + EGb and isorhamnetin + caffeic acid
H2O2 production Rate (μM/min) Ratio O E γ
C-3 + EGb 5:1 0.339 ± 0.013* 0.285 ± 0.014 1.192
3:1 0.300 ± 0.019 0.278 ± 0.013 1.080
1:1 0.274 ± 0.014 0.257 ± 0.012 1.068
1:3 0.252 ± 0.013 0.236 ± 0.014 1.067
1:5 0.238 ± 0.013 0.229 ± 0.014 1.041
Isorhamnetin +
Caffeic acid
5:1 0.481 ± 0.001* 0.319 ± 0.003 1.509
3:1 0.490 ± 0.001* 0.321 ± 0.002 1.524
1:1 0.503 ± 0.001* 0.327 ± 0.001 1.536
1:3 0.444 ± 0.003* 0.334 ± 0.001 1.331
1:5 0.399 ± 0.002* 0.336 ± 0.001 1.189
Values are the mean of three replicates ± SD (n = 3)
The asterisk indicates a significant difference between observed value and expected value (p < 0.05). O, observed value; E, expected value; γ, interaction index
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Table 4 Influence of C-3 + EGb and isorhamnetin + caffeic acid on CAT, POD, SOD and GSH enzyme activities
Combinations Ratios CAT activity U/mg prot POD activity U/mg prot SOD activity U/mg prot GSH activity U/mg prot
O E γ O E γ O E γ O E γ
C-3 + EGb 5:1 10.578 ± 0.067 10.613 ± 0.085 0.997 84.837 ± 1.901 83.467 ± 0.900 1.016 90.775 ± 1.038 88.600 ± 1.257 1.025 114.376 ± 1.697 113.692 ± 1.529 1.006
3:1 10.465 ± 0.058* 10.936 ± 0.073 0.957 80.115 ± 0.847 79.996 ± 0.755 1.001 98.150 ± 0.051 85.525 ± 1.551 1.148 110.222 ± 1.880 109.027 ± 1.956 1.011
1:1 13.175 ± 0.071* 11.908 ± 0.066 1.106 78.015 ± 0.798 69.581 ± 0.724 1.121 105.125 ± 0.073* 76.325 ± 1.356 1.377 102.312 ± 1.587 95.031 ± 1.365 1.077
1:3 12.883 ± 0.120 12.880 ± 0.090 1.000 59.346 ± 0.736 59.166 ± 0.686 1.003 66.500 ± 1.112 67.125 ± 1.193 0.991 82.964 ± 1.373 81.036 ± 1.703 1.024
1:5 13.315 ± 0.083 13.204 ± 0.068 1.008 57.514 ± 0.681 55.695 ± 0.949 1.033 67.800 ± 0.178 64.050 ± 1.138 1.058 78.2775 ± 1.541 76.371 ± 1.143 1.025
Isorhamneti + Caffeic acid 5:1 9.297 ± 0.054 8.878 ± 0.079 1.047 77.455 ± 0.618 72.404 ± 0.610 1.070 107.130 ± 1.690 109.134 ± 1.772 0.982 102.798 ± 1.105 99.666 ± 0.776 1.032
3:1 8.445 ± 0.078 8.520 ± 0.069 0.991 85.398 ± 0.759 83.218 ± 0.675 1.026 107.418 ± 1.438 103.410 ± 1.858 1.039 96.300 ± 1.230 95.760 ± 0.549 1.006
1:1 10.699 ± 0.101* 7.445 ± 0.066 1.437 119.896 ± 0.538 115.659 ± 0.871 1.037 125.970 ± 1.681* 86.244 ± 1.112 1.461 82.170 ± 0.776 84.078 ± 1.074 0.977
1:3 6.729 ± 0.067 6.371 ± 0.082 1.056 164.424 ± 0.620 148.100 ± 0.670 1.110 71.928 ± 1.925 69.078 ± 1.368 1.041 74.412 ± 0.680 72.396 ± 1.187 1.028
1:5 6.729 ± 0.064 6.013 ± 0.063 1.119 160.563 ± 0.386 158.913 ± 0.322 1.010 62.376 ± 1.673 63.360 ± 1.453 0.985 69.966 ± 0.845 68.490 ± 1.192 1.021
Values are the mean of three replicates ± SD (n = 3)


















In addition, the combinations of C-3 + EGb and iso-
rhamnetin + caffeic acid were evaluated for their antioxi-
dant capacities as isobolographic plots showed in Figs. 5
and 6. Accordingly, the combination of isorhamnetin +
caffeic acid showed obvious synergy in the CAT and
SOD enzyme activity at the ratio 1:1, suggesting that iso-
rhamnetin and caffeic acid may be the main compounds
that affected the enzyme activities in E. coli.
Similar to the results in previous chapter, other ratios
of the two combinations showed simple additive effects,
which could be speculated that the related bioactive
mechanism of combined compounds closely linked to
the effects of antioxidant enzyme activities.
Influence of C-3 + EGb and isorhamnetin + caffeic acid
on CAT, SODa, SODb and SODc gene expression by
real-time PCR
To reveal the reason why the combinations of C-3 +
EGb and isorhamnetin + caffeic acid promoted CAT and
SOD enzyme activities, influence on CAT, SODa, SODb
and SODc gene expression were measured by real-time
PCR. Among the results, C-3 + EGb and isorhamnetin +
Fig. 5 Isobolographic plot of C-3 + EGb on CAT, POD, SOD and GSH-PX enzyme activities
Fig. 6 Isobolographic plot of isorhamnetin + caffeic acid on CAT, POD, SOD and GSH-PX enzyme activities
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Table 5 Influence of C-3 + EGb and isorhamnetin + caffeic acid on CAT, SODa, SODb and SODc gene expression
Combinations Ratios CAT SODa SODb SODc
O E γ O E γ O E γ O E γ
C-3 + EGb 5:1 1.070 ± 0.029 1.102 ± 0.019 0.971 1.158 ± 0.026 1.031 ± 0.026 1.123 1.301 ± 0.012 1.370 ± 0.013 0.949 1.409 ± 0.063 1.394 ± 0.021 1.011
3:1 1.100 ± 0.071* 1.112 ± 0.014 0.990 1.027 ± 0.016 1.081 ± 0.034 0.950 1.322 ± 0.044 1.384 ± 0.019 0.955 1.423 ± 0.030 1.409 ± 0.013 1.010
1:1 1.279 ± 0.140* 1.141 ± 0.023 1.122 1.569 ± 0.045 1.231 ± 0.059 1.275 1.528 ± 0.020 1.424 ± 0.038 1.073 1.522 ± 0.070 1.454 ± 0.054 1.047
1:3 1.022 ± 0.006 1.170 ± 0.025 0.874 1.207 ± 0.023 1.380 ± 0.083 0.874 1.428 ± 0.081 1.464 ± 0.056 0.976 1.457 ± 0.076 1.499 ± 0.083 0.972
1:5 1.028 ± 0.011 1.180 ± 0.028 0.871 1.334 ± 0.022 1.430 ± 0.091 0.933 1.443 ± 0.010 1.478 ± 0.063 0.977 1.501 ± 0.071 1.514 ± 0.025 0.991
Isorhamnetin + Caffeic acid 5:1 1.283 ± 0.065 1.289 ± 0.025 0.995 1.220 ± 0.016 1.289 ± 0.013 0.946 1.206 ± 0.027 1.183 ± 0.025 1.020 1.342 ± 0.047 1.347 ± 0.046 0.996
3:1 1.264 ± 0.018 1.292 ± 0.049 0.979 1.300 ± 0.008 1.315 ± 0.011 0.989 1.135 ± 0.021 1.171 ± 0.026 0.969 1.348 ± 0.033 1.338 ± 0.004 1.007
1:1 1.395 ± 0.004 1.298 ± 0.012 1.075 1.685 ± 0.019* 1.391 ± 0.049 1.211 1.289 ± 0.040 1.135 ± 0.028 1.135 1.477 ± 0.020* 1.310 ± 0.018 1.127
1:3 1.352 ± 0.047 1.305 ± 0.019 1.036 1.467 ± 0.009 1.467 ± 0.011 1.000 1.080 ± 0.017 1.100 ± 0.030 0.982 1.227 ± 0.018 1.282 ± 0.027 0.957
1:5 1.321 ± 0.002 1.307 ± 0.021 1.011 1.512 ± 0.025 1.492 ± 0.031 1.013 1.109 ± 0.006 1.088 ± 0.031 1.019 1.233 ± 0.021 1.273 ± 0.089 0.968
Values are the mean of three replicates ± SD (n = 3)


















caffeic acid promoted CAT and SODa gene expression
and the ratio 1:1 of two combinations exhibited the
strongest promotion with value of 1.279 ± 0.140, 1.569 ±
0.045, 1.395 ± 0.004 and 1.685 ± 0.019 (γ = 1.122, 1.275,
1.075 and 1.211) respectively (Table 5). However, the
combinations of C-3 + EGb and isorhamnetin + caffeic
acid did not promote SODb and SODc gene expression
so significant.
Similarly, isobolographic plot of C-3 + EGb and iso-
rhamnetin + caffeic acid on CAT, SODa, SODb and SODc
gene expression both showed significant synergistic pro-
moting effect on CAT and SODa gene expression and
the synergy was most significant at the ratio 1:1 (Figs. 7
and 8). The results also showed that the combination of
C-3 + EGb just displayed an additive effect in SODb and
SODc gene expression as well as the combination of iso-
rhamnetin + caffeic acid.
In conclusion, the changes in gene expression may be
closely linked to those in enzyme activity. The results
showed the combination of isorhamnetin + caffeic acid
promoted CAT and SODa gene expression and had no
obvious promoting effect on SODb and SODc gene ex-
pression. This further explain that the synergistic effects
of C-3 combined with EGb may have relations with its
components of isorhamnetin and caffeic acid. Interac-
tions between isorhamnetin and caffeic acid may played
Fig. 7 Influence of C-3 + EGb on CAT, SODa, SODb and SODc gene expression
Fig. 8 Influence of isorhamnetin + caffeic acid on CAT, SODa, SODb and SODc gene expression
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an important role in the related bioactive mechanism
behind synergism. However, the problem still needs fur-
ther research.
Conclusions
In conclusion, the combination of C-3 + EGb in various
ratios exhibited significant synergistic effect on MTS and
the ratio 5:1(C-3: EGb) showed the strongest synergy.
Similarly, the combination of isorhamnetin + caffeic acid
also displayed synergistic effect on MTS and the ratio 1:1
exhibited the strongest synergy. These results were in
accordance with that determined in H2O2 antioxidant
production rate. Furthermore, both combinations of C-3
+ EGb and isorhamnetin + caffeic acid promoted CAT and
SOD enzyme activities and the ratio 1:1 exhibited the
strongest synergy. What’s more, both combinations above
promoted gene expression of CAT and SOD enzyme and
the ratio 1:1 exhibited the strongest synergy. Therefore,
the related bioactive mechanism behind the synergism of
C-3 combined with EGb may be attributed to the combin-
ation of isorhamnetin and caffeic acid which promoted
gene expression of CAT and SOD enzyme as well as fur-
ther promoted CAT and SOD enzyme activities thus
showed synergistic effect.
P. fruticosa extracts have long been used for its super-
ior therapeutic in traditional Tibetan medicine in China.
This study provided relevant theoretical basis for maxi-
mizing biological antioxidant capacity and physiological
bioavailability of P. fruticosa using EGb in lower doses to
avoid the side effects. Moreover, isorhamnetin + caffeic
acid could be used as the specific combination that ex-
hibit synergistic effect of P. fruticosa combined with
EGb. These results could also be useful to elaborate the
related bioactive mechanism behind the synergy of P.
fruticosa combined with EGb for theoretical guidance to
develop new medicines and natural products. Neverthe-
less, more researches need to be conducted to explain
fundamental reason.
Abbreviations
ANOVA: Analysis of variance; C-3: P. fruticosa leaf extracts (the acetone
extraction phase); CAT: Catalase enzyme; EGb: Ginkgo biloba extracts; GSH-
PX: Glutathione peroxidase enzyme; MTS: Microbial test system;
POD: Peroxidase enzyme; SOD: Superoxide dismutase enzyme
Acknowledgments
This work was supported by the program from the Fundamental Research
Funds for the Central Universities (ZD2013010).
Availability of data and materials
The datasets supporting the conclusions of this article are included within
the article.
Authors’ contributions
DMW and DWL conceived and designed the experiments. ZHL performed
the experiments and analyzed the data. SFF and ZWL helped with the
experiment. ZHL, DWL and DMW wrote the paper. DMW critically revised the
paper. All authors read and approved the final manuscript.
Competing interests
All the authors declare no present or potential conflicts of interest. All
authors are responsible for the content and writing of the paper and
approved of its publication.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Not applicable.
Received: 27 May 2016 Accepted: 14 November 2016
References
1. Capecka E, Mareczek A, Leja M. Antioxidant activity of fresh and dry herbs
of some Lamiaceae species. Food Chem. 2005;93:223–6.
2. Elham RN, Alireza SM, Mohammad G, Mehdi K. Evaluation of antioxidant
interactions in combined extracts of green tea (Camellia sinensis), rosemary
(Rosmarinus officinalis) and oak fruit (Quercus branti). J Food Sci Technol.
2015;52(7):4565–71.
3. Liu W, Wang DM, Liu JJ, Li DW, Yin DX. Quality Evaluation of Potentilla
fruticosa L. by High Performance Liquid Chromatography Fingerprinting
Associated with Chemometric Methods. PLoS One. http://dx.doi.org/10.
1371/journal.pone.0149197.
4. Wang SS, Wang DM, Pu WJ, Li DW. Phytochemical profiles, antioxidant and
antimicrobial activities of three Potentilla species. BMC Complement Altern
Med. 2013;13:321.
5. Flora reipublicae popularis sinicae. Chinese: 1985. Tomus 37. P.244.
6. Wang SS, Wang DM, Liu ZH. Synergistic, additive and antagonistic effects of
Potentilla fruticosa combined with EGb761 on antioxidant capacities and the
possible mechanism. Ind Crop Prod. 2015;67:227–38.
7. Bai DY, Ma MC, Zhang ZH. Analysis of leaf ingredient in wild Potentilla
fruticosa L. of different elevation. Chin Agric Sci Bulletin. 2007;16:371–3.
8. Li HC, Sun HZ, Hu X. Analysis on total flavonoid in leaves of Potentiila
fruticosa in different environment and related mechanism. Western forestry
science. 2007;36:71–4.
9. Qiao Yin. Research on pharmacological activity of Potentilla L. China modern
medicine. 2009; 16: 107.
10. Tomczyk M, Leszczyńska K, Jakoniuk P. Antimicrobial activity of Potentilla
species. Fitoterapia. 2008;79:592–4.
11. Wang QJ, Zhou XM, Zhang YQ. Structure characteristics and biomass of
Potentilla fruticosa shrub in Qinghai-Tibet Plateau. Acta Bot Boreali - occiden
Sin. 1991;11:333–40.
12. Shimono A, Ueno S, Gu S, Zhao X, Tsumura Y, Tang Y. Range shifts of
Potentilla fruticosa on the Qinghai-Tibetan Plateau during glacial and
interglacial periods revealed by chloroplast DNA sequence variation.
Heredity. 2009;104:534–42.
13. Shushunov S, Balashov L, Kravtsova A, Krasnogorsky I, Latte KP, Vasiliev A.
Detemination of acute toxicity of the aqueous extracts of Potential erecta
(Tormentil) rhizomes in rats and mice. J Med Food. 2009;12:1173–6.
14. Tomczyk M, Latte KP. Potentilla-A review of its phytochemical profile.
J Ethnopharmacol. 2009;122:184–204.
15. Tomczyk M, Drozdowska D, Bielawska A, Bielawski K, Gudej J. Human DNA
topoisomerases inhibitors from Potentilla argentea and their cytotoxic effect
against MCF-7. Pharmazie. 2008;63:389–93.
16. Tomczyk M, Leszczynska K, Tomczykowa M, Jakoniuk P. Screening of
antimicrobial activity of aqueous extracts of the selected Potentilla L.
species. Planta Med. 2009;73:854–5.
17. Tomczyk M. Secondary metabolites from Potentilla argentea. Biochem Syst
Ecol. 2006;34:770–3.
18. Miliauskas G, Venskutonis P, Van Beek T. Screening of radical scavenging activity
of some medicinal and aromatic plant extracts. Food Chem. 2004a; 85: 231–237.
19. Miliauskas G, Van Beek TA, Venskutonis PR, Linssen JP, de Waard P,
Sudhölter EJ. Antioxidant activity of Potentilla fruticosa. J. Sci. Food Agric.
2004b; 84: 1997–2009.
20. Tomczyk M, Pleszczynska M, Wiater A. Variation in total polyphenolics
contents of aerial parts of Potentilla species and their anticariogenic activity.
Molecules. 2010;15:4639–51.
Liu et al. BMC Complementary and Alternative Medicine  (2016) 16:495 Page 13 of 14
21. Haramaki N, Aggarwal S, Kawabata T, Droy MTT, Packer L. Effects of natural
antioxidant Ginkgo biloba extract (EGB 761) on myocardial ischemia-
reperfusion injury. Free Radical Biol Med. 1994;16:789–94.
22. Van Beek TA. Chemical analysis of Ginkgo biloba leaves and extracts.
J Chromatogr A. 2002;967:21–55.
23. Diamond BJ, Bailey MR. Ginkgo biloba: Indications, Mechanisms, and Safety.
Psychiatr. Clin N Am. 2013;36:73–83.
24. Giedrius M, Teris A, Petras RV, Jozef PH, Pieter W, Ernst JR, Sudhölter.
Antioxidant activity of Potentilla fruticosa. J Sci Food Agric. 2004;84:1997–2009.
25. Ding XP, Wang XT, Xu T, Qi J, Wang H, Yu BY. Comparison of Two On-Line
Analysis Techniques Used for the Screening of Antioxidants in EGb 761.
J Chromatogr A. 2010;71:493–7.
26. Zhang J, Yue L, Khizar H, Xia S, Zhang XM, Ding BM, Tong JM, Chen ZX.
Purification of flavonoid from Gingko biloba extract by zinc complexation
method and its effect on antioxidant activity. Sep Purif Technol. 2010;71:273–8.
27. Zhou D, Wang DM, Yang LN, Liu ZH, Zhang YW. A Modified and Improved
Assay Based on Microbial Test System (MTS) to Evaluate Antioxidant
Activity. Food Anal Methods. 2015;9(4):895–904.
28. Seaver L, Imlay J. Alkylhydro peroxide reductase is the primary scavenger of
endogenous hydrogen peroxide in Escherichia coli. J Bacteriol. 2001;183:7173–81.
29. Beers R, Sizer I. Colorimetric method for estimation of catalase. J Biol Chem.
1952;195:133–9.
30. Huang XS, Wang W, Zhang Q, Liu JH. A basic helix-loop-helix transcription
factor, PtrbHLH, of poncirus trifoliate confers cold tolerance and modulates
peroxidase-mediated scavenging of hydrogen peroxide. Plant Physiol.
2013;162:1178–94.
31. Weng SF, Zhang XL. The measurement of serum SOD xanthine oxidase
conditions. J Foshan Univ. 2011;29(3):65–7.
32. Xing BY, Zhu N, Zhang HP, Yang XL, Dong JE. Effects of methyl viologen on
the antioxidant system in cultured Salvia miltiorrhiza cells. Chin J Plant Ecol.
2014;38(5):507–14.
33. Tallarida RJ. Drug synergism: its detection and applications. J Pharmacol Exp
Ther. 2001;298:865–72.
34. Tallarida RJ. An overview of drug combination analysis with isobolograms.
J Pharmacol Exp Ther. 2006;319:1–7.
35. Lansky EP, Jiang W, Mo H, Bravo L, Froom P, Yu W, Harris NM, Neeman I,
Campbell MJ. Possible synergistic prostate cancer suppression by anatomically
discrete pomegranate fractions. Invest New Drugs. 2005;23:11–20.
36. Li SM, Campbell BL, Katz JL. Interactions of cocaine with dopamine uptake
inhibitors or dopamine releasers in rats discriminating cocaine. J Pharmacol
Exp Ther. 2006;317:1088–96.
37. Chen CY, Milbury PE, Lapsley K, Blumberg JB. Flavonoids from almond skins
are bioavailable and act synergistically with vitamins C and E to enhance
hamster and human LDL resistance to oxidation. J Nutr. 2005;135:1366–73.
38. Viera L, Marques A, Barros L, Barriera J, Ferriera I. Insights in the antioxidant
synergistic effects of combined edible mushrooms: phenolis and
polysaccharridic extracts of Boletus edulis and Marasmius oreades. J Food
Nutr Res. 2012;51(2):109–16.
39. Heo HJ, Kim YJ, Chung D, Kim DO. Antioxidant capacities of individual and
combined phenolics in a model system. Food Chem. 2007;104:87–92.
40. Kirakosyan A, Mitchell Seymour E, Noon KR, Urcuyo Llanes DE, Kaufman PB,
Warber SL, Bolling SF. Interactions of antioxidants isolated from tart cherry
(Prunus cerasus) fruits. Food Chem. 2010;122:78–83.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Liu et al. BMC Complementary and Alternative Medicine  (2016) 16:495 Page 14 of 14
